ESMO Preceptorship on Colorectal Cancer Vienna

Oncology Meeting Resources

26 Oct - 27 Oct, Vienna, Austria

ESMO Preceptorship on Colorectal Cancer

The aims of this Preceptorship were to learn about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings; to understand the importance of pathology and histoprognostic factors; and to learn about the management of patients after progression, side effects of treatments, and in special situations.

On this page, you may download the PDF of presentations given at the ESMO Preceptorship on Colorectal Cancer 2015 Vienna to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Search Meeting Resources by Keyword

Useful links

Presenter Presentation title Session title
J. Douillard, FR Multidisciplinary management, standards of care and future perspectives Welcome and introduction
D. Aust, DE Early (and not so early) colorectal cancer:
 The pathologist’s point of view Session 1 Early colorectal cancer
C. Köhne, DE Development of conventional chemotherapy Session 3: Metastatic colorectal cancer, liver limited metastases
C. Köhne, DE Unresectable or boarderline resectable (Group 1) chemotherpy +/- targeted agents Session 3: Metastatic colorectal cancer, liver limited metastases
P. Kumar, IN Carcinoma rectum Session 2 Adjuvant settings of colorectal cancer
D. Aust, DE MSI and other molecular markers:
 how useful are they? Session 2 Adjuvant settings of colorectal cancer
J. Douillard, FR Adjuvant Chemotherapy for Stage II colon Cancer:
 for which patients? Session 2 Adjuvant settings of colorectal cancer
C. Köhne, DE First line treatment in metastatic colorectal cancer Session 5 Metastatic colorectal cancer I
W. Scheithauer, AU What to do after 1st-line failure in mCRC ? Session 6 Metastatic colorectal cancer II
J. Douillard, FR Review of the ESMO Consensus Conference on metastatic colo-rectal cancer
Basic strategy and groups (RASwt/mut, BRAF mut) Session 3: Metastatic colorectal cancer, liver limited metastases
R. Glynne-Jones, UK State‐of‐the‐art: Standard(s) of radio/chemotherapy for rectal cancer Session 1 Early colorectal cancer
A. Piciu, RO Multiple metastatic colon adenocarcinoma Session 6 Metastatic colorectal cancer II
S.P. Chaudhary, IN Treatment Challenges in the mCRC after failure of multiple lines therapy Session 6 Metastatic colorectal cancer II
R. Glynne-Jones, UK State of the art multimodal treatment of anal cancer
 Session 7 Anal Canal tumors
U. Bokal, SI Advanced adenocarcinoma of the caecum Session 2 Adjuvant settings of colorectal cancer